Onglyza And The Type 2 Diabetes Approval Roadmap
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's approval of Bristol/AstraZeneca's type 2 diabetes drug sets a precedent for what kind of post-marketing work will be necessary.